NT-101 ophthalmic solution

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

NT-101 ophthalmic solution
Treatment and conditionWhere it standsTrials
NT-101 ophthalmic solution for macular degenerationPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1